Metal-based compounds may be the future of antibiotics

Robots can help develop them

Devika Rao, The Week US's avatar
By Devika Rao, The Week US

published yesterday

Metallic medicine

 

Researchers used robots and “click chemistry,” a “method where two molecular components are ‘bolted’ together efficiently,” to produce over 600 compounds, said the release. “We opted to use liquid-handling robots to do the chemistry because it’s just combining different reagents in the right ratios,” said Angelo Frei, the lead author of the study, to Live Science. This method allowed for the rapid testing of the compounds, turning months of work into just days, though careful checks were still required.

An iridium metal complex was specifically identified as a promising antibiotic drug. It “demonstrated high effectiveness against bacteria, including strains similar to the deadly MRSA (Methicillin-resistant Staphylococcus aureus), while displaying low toxicity to human cells,” said the release. The compound was “about 50 to 100 times more active against bacteria than it was toxic to human cells,” a difference that is “vital to ensure that the complex is simultaneously effective in treating an infection but safe to use on human tissues,” said Live Science.

Revved-up research

The findings come at a time when antibiotic resistance is becoming more of a danger. “The pipeline for new antibiotics has been running dry for decades,” Frei said in the release. “Traditional screening methods are slow and the pharmaceutical industry has largely withdrawn from this space due to low returns on investment. We have to think differently.” Different metal compositions “can hit bacteria in several ways, which matters when single-target drugs stop working,” said Earth.com. A metal center “can change its charge and grip key bacterial proteins, which can stall processes needed for growth.”

There has been a “misconception that metal-based drugs are inherently toxic,” said the release. However, “metal complexes actually have a higher ‘hit rate’ for being antibacterial without being toxic compared to standard organic molecules.” Still, because bacteria evolve quickly, there is a risk of resistance developing to these compounds over time. The good news is that robotic chemistry can significantly speed up research. “The iridium compound we discovered is exciting, but the real breakthrough is the speed at which we found it,” Frei said. “This approach could be the key to avoiding a future where routine infections become fatal again.” The method could also be used beyond antibiotics and help further several areas of biomedical research.

Devika Rao, The Week US
Devika Rao, The Week US

 Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.

Facebook
Twitter
LinkedIn
Pinterest
Email

Related Posts

What is hyperphosphatemia?

Symptoms Causes Diagnosis Treatment Prevention Outlook Excess phosphate in the blood is known as hyperphosphatemia. The most common cause is kidney disease, but other conditions

Read More »
Scroll to Top